PTC Therapeutics to Present at the Evercore ISI 2nd Annual HealthCONx Conference

Nov 19, 2019

Posted by PTC Therapeutics, Inc.

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will participate in a panel discussion titled, "Gene Therapy with Base Business – Extracting Value," at the 2nd Annual Evercore ISI HealthCONx Conference on Tuesday, December 3rd at 2:45 p.m. ET.

The panel discussion will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. PTC's current Corporate Presentation is available at the same website location.

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.




Jane Baj                          

Alex Kane

+1 (908) 912-9167             

+1 (908) 912-9643            

See all Member News